Medicine price: quote on request. Your total cost is quoted in writing per case.
We give you a written timeline estimate for your case before you commit.
Ask about Enhertu

Is Enhertu available in the UAE? Status, route and cost

A plain answer for families in the UAE, checked against FDA, regulator and manufacturer sources on 17 October 2026.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Is Enhertu available in the UAE?

Enhertu has an active code in Abu Dhabi's official drug list (checked 17 October 2026); its federal status is unverified. It is a HER2-directed antibody-drug conjugate for several HER2-driven cancers, including breast cancer. In Abu Dhabi, your specialist can prescribe it through a hospital that stocks it. Elsewhere in the UAE, the hospital pharmacy confirms status first.

  • Registration: Listed with an active code (B48-8000-10793-02) in the Abu Dhabi Department of Health (DoH) drug code list (release of 26 September 2026); we could not verify its federal EDE status.
  • Access route: Prescription through a hospital that stocks it (listed in Abu Dhabi); elsewhere the hospital confirms status first.
  • Who acts: your treating specialist and hospital; the hospital pharmacy orders it.
  • Timeline: We give you a written timeline estimate for your case before you commit.
  • Price: Medicine price: quote on request.

Status in the UAE, with dates

  • Enhertu has an active code (B48-8000-10793-02) in the Abu Dhabi DoH drug code list, release of 26 September 2026. (source)

What Enhertu is

Enhertu (fam-trastuzumab deruxtecan) is made by Daiichi Sankyo (with AstraZeneca). The US FDA first approved Enhertu on 20 December 2019. Its US approvals now include HER2-positive breast cancer (including first-line use with pertuzumab from December 2025 and early breast cancer from May 2026), HER2-low and HER2-ultralow metastatic breast cancer, HER2-mutant lung cancer, HER2-positive stomach cancer, and HER2-positive (IHC 3+) solid tumors (accelerated approval, April 2024).

How it is given: An intravenous (IV) infusion given in an oncology unit, in repeated cycles decided by the oncologist. It carries serious warnings, including lung inflammation (interstitial lung disease), that your oncologist will explain and monitor.

How access works in the UAE

Because Enhertu is listed in Abu Dhabi, a specialist can prescribe it through a hospital that stocks it, and the hospital pharmacy orders it through the local supply channel. A named-patient import is meant for medicines that are not registered, so it is not the usual route.

If your hospital cannot obtain it, ask the hospital pharmacy why. The reason may be stock, the hospital formulary or funding, and each has a different answer.

The Abu Dhabi list covers coded products in that emirate. Ask the hospital pharmacy to confirm the current status with EDE and, for Abu Dhabi or Dubai hospitals, with DoH or DHA.

If a hospital outside Abu Dhabi needs to import it:

The Emirates Drug Establishment (EDE) is the UAE's federal medicines regulator. It was created by Federal Decree No. 28 of 2023 and took over the medicines role of the Ministry of Health and Prevention (MOHAP). Medicines normally have to be registered before they are used.

For a medicine that is not registered, the treating hospital asks for approval to import it for a specific patient. The hospital signs an undertaking that it takes responsibility for the medicine's use and shows that the medicine is registered in its country of origin. FDA approval makes this easier. The medicine stays inside the hospital system and cannot be resold.

Hospitals in Abu Dhabi are licensed by the Department of Health (DoH), and hospitals in Dubai by the Dubai Health Authority (DHA). Your hospital pharmacy knows which office handles the file for your hospital today.

Who does what

  • Your treating specialist decides whether Enhertu is right for the patient and writes the referral or prescription.
  • The hospital or treatment center orders and gives the medicine, and is responsible for using it safely.
  • The Emirates Drug Establishment (EDE) registers medicines and decides on any import request for a medicine that is not registered.
  • Daiichi Sankyo (with AstraZeneca) makes Enhertu and decides where it can be supplied.
  • Reserve Meds helps your family understand the steps, organizes records and communication, and, where an import is needed, arranges US supply through our licensed wholesale partner. We do not give medical advice.

Documents you will usually need

  • The HER2 test result (HER2-positive, HER2-low or ultralow, or HER2 mutation) that matches the approved use
  • A prescription or treatment plan from the specialist, with the dose and duration
  • Recent clinic notes and laboratory results
  • For an import request: the hospital's request form, its signed declaration of responsibility, written patient consent, and proof of the US FDA approval (we can supply the US prescribing information)

Steps

  1. Assessment. Your specialist confirms that the patient fits the approved use and orders the needed tests.
  2. Prescription. The specialist prescribes it at a hospital that stocks it.
  3. Supply. The hospital pharmacy orders it through the local supply channel.
  4. Treatment. The patient starts treatment with the monitoring the label requires.

Timeline and cost

We give you a written timeline estimate for your case before you commit. The treating center, the regulator and the manufacturer set their own timelines.

Medicine price: quote on request. Your total cost depends on the dose, travel or shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate access to FDA-approved medicines only. We help your family understand the route, organize records and communication with the hospital or center, and, where an import is approved, arrange US supply and shipping. We do not prescribe, and we do not decide what the regulator or a treatment center approves.

Ask about Enhertu in the UAE

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Include the country code, for example +966 or +971.
Message us on WhatsApp

No account needed. We reply within one business day. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Abu Dhabi and Dubai

This guide covers the whole UAE, including Abu Dhabi and Dubai. At federal level, medicines are regulated by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). MOHAP also issues permits to import medicines for personal use. Hospitals, clinics and doctors are licensed by the health authority of their own emirate: the Department of Health Abu Dhabi (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA) in Dubai.

In practice, the hospital that treats you follows the rules of its own emirate, so the paperwork is prepared for that hospital. Tell us which hospital or doctor is treating you, in Abu Dhabi, Dubai or another emirate, and we prepare the document pack for that route.

Sources: Department of Health Abu Dhabi; Dubai Health Authority, Health Regulation Sector; MOHAP, permit to import medicines for personal use; Simmons & Simmons, UAE pharmaceutical law and the Emirates Drug Establishment.

Frequently asked questions

Is Enhertu registered in the UAE?

Enhertu has an active code in Abu Dhabi's official drug list (checked 17 October 2026); its federal status is unverified. The Abu Dhabi list covers coded products in that emirate. Ask the hospital pharmacy to confirm the current status with EDE and, for Abu Dhabi or Dubai hospitals, with DoH or DHA.

How do patients in the UAE get Enhertu?

It is a HER2-directed antibody-drug conjugate for several HER2-driven cancers, including breast cancer. In Abu Dhabi, your specialist can prescribe it through a hospital that stocks it. Elsewhere in the UAE, the hospital pharmacy confirms status first.

How long does it take to get Enhertu in the UAE?

We give you a written timeline estimate for your case before you commit. The treating center, the regulator and the manufacturer set their own timelines, and we tell you honestly what depends on them.

How much does Enhertu cost?

Medicine price: quote on request. Your total cost, including any travel, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Can Enhertu be sent to our home?

No. Enhertu goes to the hospital that will give it, never to a home address. Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not a pharmacy.

Sources

Checked on 17 October 2026. Regulator rules and lists change. Your hospital pharmacy or treatment center confirms the current position before anything is filed.

  1. Drugs.com: Enhertu FDA approval history (2019 to May 2026)
  2. Daiichi Sankyo (Business Wire): ENHERTU approved in the US for HER2-low metastatic breast cancer, 5 Aug 2022
  3. Abu Dhabi Department of Health: drug code list (release of 26 Sep 2026, checked 17 Oct 2026)
  4. Baker McKenzie: Emirates Drug Establishment replaces MOHAP as federal regulator of medical products (Federal Decree No. 28 of 2023)
  5. Al Tamimi & Co: importation of unregistered drugs in the UAE (hospital undertaking; registration in country of origin)

Related

WhatsApp